In re Schering Plough Corp. Intron/Temodar Consumer Class Action, Nos. 10-3046 and 10-3047; Third Circuit; opinion by Vanaskie, U.S.C.J.; filed May 16, 2012. Before Judges Sloviter, Vanaskie and Greenberg. On appeal from the District of New Jersey. [Sat below: Judge Chesler.] [35 pp.]
In June 2001, the Food and Drug Administration’s Division of Drug Marketing, Advertising and Communications sent Schering Sales Corporation a letter notifying it that the FDA had identified various promotional activities that were in violation of the Food, Drug and Cosmetic Act (FDCA) and its implementing regulations.
